Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer

Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investig...

Full description

Saved in:
Bibliographic Details
Published inPhytomedicine (Stuttgart) Vol. 57; pp. 117 - 128
Main Authors Wang, Lai, Liu, Yang, Zhao, Ting-Li, Li, Zheng-Zheng, He, Jin-Yong, Zhang, Ben-Jia, Du, Hong-Zhi, Jiang, Jing-Wei, Yuan, Sheng-Tao, Sun, Li
Format Journal Article
LanguageEnglish
Published Germany Elsevier GmbH 01.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investigate the effect of TPT on metabolism in gastric cancer. ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting. TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT. TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT. [Display omitted]
AbstractList BACKGROUNDTopotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown.PURPOSETo investigate the effect of TPT on metabolism in gastric cancer.METHODSATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting.RESULTSTPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT.CONCLUSIONTPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT.
Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investigate the effect of TPT on metabolism in gastric cancer. ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting. TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT. TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT.
Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investigate the effect of TPT on metabolism in gastric cancer. ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting. TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT. TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT. [Display omitted]
Author Li, Zheng-Zheng
He, Jin-Yong
Du, Hong-Zhi
Yuan, Sheng-Tao
Sun, Li
Zhao, Ting-Li
Zhang, Ben-Jia
Liu, Yang
Wang, Lai
Jiang, Jing-Wei
Author_xml – sequence: 1
  givenname: Lai
  surname: Wang
  fullname: Wang, Lai
  organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 2
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
  organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 3
  givenname: Ting-Li
  surname: Zhao
  fullname: Zhao, Ting-Li
  organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 4
  givenname: Zheng-Zheng
  surname: Li
  fullname: Li, Zheng-Zheng
  organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 5
  givenname: Jin-Yong
  surname: He
  fullname: He, Jin-Yong
  organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 6
  givenname: Ben-Jia
  surname: Zhang
  fullname: Zhang, Ben-Jia
  organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 7
  givenname: Hong-Zhi
  surname: Du
  fullname: Du, Hong-Zhi
  organization: School of Pharmacy, Hubei University of Chinese Medicine, Huang jia hu Road West, Wuhan, China
– sequence: 8
  givenname: Jing-Wei
  surname: Jiang
  fullname: Jiang, Jing-Wei
  organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 9
  givenname: Sheng-Tao
  surname: Yuan
  fullname: Yuan, Sheng-Tao
  email: yuanst@cpu.edu.cn
  organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
– sequence: 10
  givenname: Li
  surname: Sun
  fullname: Sun, Li
  email: sunli@cpu.edu.cn
  organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30668314$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtLAzEQx4NUbH18A5EcveyaSdLt5iKU4gsEESt4CzGZ1ZR2sybbot_elNarpxmY_4P5HZNBG1ok5BxYCQyqq0XZff6s0JWcQV0CLxnAARlBBXXB1PhtQEZMSVlMAMSQHKe0YAykmrAjMhSsqmoBckSe56ELPVrTUt-6tcVETRe6PiSf6MYbOn2ZzTnNPd706Gj49s70foM09RFTyi76YfLuLc0hFuMpOWzMMuHZfp6Q19ub-ey-eHy6e5hNHwsrKt4XzqJFFGNXG8UbNa5cIyonnWUN52OpuEXTGCYMYxLYpFI1SO6UNaJuQCgjTsjlLreL4WuNqdcrnywul6bFsE6aw0RJLkStslTupDaGlCI2uot-ZeKPBqa3MPVC72DqLUwNXGeY2Xaxb1i_b29_pj96WXC9E2D-c-Mx6mQ9ZgjOR7S9dsH_3_ALjSeJuw
CitedBy_id crossref_primary_10_1007_s10863_024_10008_z
crossref_primary_10_1007_s10616_023_00588_w
crossref_primary_10_1007_s12094_023_03278_3
crossref_primary_10_1080_01635581_2022_2076889
crossref_primary_10_1158_1535_7163_MCT_20_0354
crossref_primary_10_3389_fonc_2019_01202
crossref_primary_10_3389_fphar_2024_1345522
crossref_primary_10_3390_cancers15205082
crossref_primary_10_1016_j_apsb_2022_07_021
crossref_primary_10_2139_ssrn_4176716
crossref_primary_10_1007_s13659_020_00283_9
crossref_primary_10_1016_j_apsb_2021_09_019
crossref_primary_10_3389_fimmu_2023_1221530
crossref_primary_10_1007_s10495_022_01709_0
crossref_primary_10_1007_s10735_022_10070_0
crossref_primary_10_1371_journal_pone_0261370
crossref_primary_10_1093_jas_skaa138
crossref_primary_10_1016_j_gastrohep_2020_05_017
crossref_primary_10_1016_j_phymed_2024_155583
crossref_primary_10_1016_j_tifs_2021_10_007
crossref_primary_10_1007_s00280_020_04218_6
crossref_primary_10_1177_15347354211045349
crossref_primary_10_1016_j_bcp_2023_115464
crossref_primary_10_1007_s11064_019_02934_x
crossref_primary_10_3390_cancers13020203
crossref_primary_10_1016_j_gastre_2020_05_011
Cites_doi 10.1172/JCI69600
10.1074/jbc.273.23.14484
10.1016/j.celrep.2014.04.045
10.1016/S0962-8924(00)01803-1
10.1016/j.bpj.2012.12.010
10.1016/j.ejphar.2017.10.014
10.1016/j.bmc.2004.11.028
10.1016/j.cmet.2015.12.006
10.3892/or.2013.2272
10.1186/s40170-015-0128-2
10.1016/j.ceb.2004.09.009
10.1146/annurev-bioeng-071516-044546
10.1126/science.1218595
10.1128/MCB.22.16.5793-5800.2002
10.1038/ncb0311-184
10.1111/bph.13765
10.1016/j.molcel.2012.05.043
10.1038/nature12040
10.18632/oncotarget.8843
10.1038/nrc3557
10.1038/onc.2015.381
10.1038/nature13236
10.1038/s41598-017-07631-9
10.3389/fonc.2012.00060
10.1074/jbc.274.17.11647
10.1002/path.4518
10.1016/j.freeradbiomed.2016.04.198
10.18632/oncotarget.19479
10.1002/msb.20134892
10.1038/nrc2663
10.1007/s00109-011-0731-9
10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4
10.1016/j.mam.2018.02.003
10.1054/bjoc.2000.1353
ContentType Journal Article
Copyright 2018
Copyright © 2018. Published by Elsevier GmbH.
Copyright_xml – notice: 2018
– notice: Copyright © 2018. Published by Elsevier GmbH.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.phymed.2018.12.011
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1618-095X
EndPage 128
ExternalDocumentID 10_1016_j_phymed_2018_12_011
30668314
S0944711318306068
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1~.
1~5
29O
3V.
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X2
7X7
88E
88I
8AF
8FE
8FH
8FI
8FJ
8P~
8R4
8R5
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AAKPP
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAWTL
AAXUO
AAYOK
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABUWG
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACGOD
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKRA
AFKWA
AFRAH
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AIXEN
AJBFU
AJOXV
AJRQY
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
ATCPS
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BES
BHPHI
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DOVZS
DU5
DWQXO
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
HCIFZ
HMCUK
HVGLF
HX~
HZ~
IAG
IAO
IEA
IHA
IHE
IHR
INH
INR
IOF
ISR
J1W
KOM
LCYCR
M0K
M1P
M2P
M2Q
M41
MO0
N9A
NAPCQ
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
PCD
PQQKQ
PROAC
PSQYO
PV9
Q2X
Q38
R2-
RIG
ROL
RPZ
RWL
RXW
RZL
S0X
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSP
SSU
SSZ
T5I
T5K
TAE
UKHRP
UNMZH
WOW
~G-
~KM
AAHBH
AAXKI
AKRWK
ALIPV
NPM
AAYXX
AFJKZ
CITATION
ITC
7X8
ID FETCH-LOGICAL-c362t-dcecee35d8a92f956df36d4dc0f225492ceafa03a004107698142d9ca38f139a3
IEDL.DBID AIKHN
ISSN 0944-7113
IngestDate Fri Aug 16 01:44:41 EDT 2024
Thu Sep 26 15:51:12 EDT 2024
Sat Sep 28 08:41:37 EDT 2024
Fri Feb 23 02:49:36 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Oxidative stress
GSSG
Topotecan
GPT
GDH
GOT
GLS
PSAT
ASCT2
α-KG
NEAAs
ROS
ME-1
TPT
Gastric cancer
GSH
GPNA
Apoptosis
Language English
License Copyright © 2018. Published by Elsevier GmbH.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c362t-dcecee35d8a92f956df36d4dc0f225492ceafa03a004107698142d9ca38f139a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30668314
PQID 2179423389
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_2179423389
crossref_primary_10_1016_j_phymed_2018_12_011
pubmed_primary_30668314
elsevier_sciencedirect_doi_10_1016_j_phymed_2018_12_011
PublicationCentury 2000
PublicationDate 2019-04-01
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Phytomedicine (Stuttgart)
PublicationTitleAlternate Phytomedicine
PublicationYear 2019
Publisher Elsevier GmbH
Publisher_xml – name: Elsevier GmbH
References Desagher, Martinou (bib0008) 2000; 10
Shanware, Mullen, DeBerardinis, Abraham (bib0027) 2011; 89
Ulrich-Merzenich, Zeitler, Vetter, Kraft (bib0030) 2009; 16
Phang, Liu, Hancock, Christian (bib0025) 2012; 2
Hensley, Wasti, DeBerardinis (bib0016) 2013; 123
Pavlova, Thompson (bib0024) 2016; 23
Jain, Nilsson, Sharma, Madhusudhan, Kitami, Souza, Kafri, Kirschner, Clish, Mootha (bib0017) 2012; 336
Hara, Yonezawa, Weng, Kozlowski, Belham, Avruch (bib0014) 1998; 273
Yang, Venneti, Nagrath (bib0034) 2017; 19
Du, Liu, Chen, Yu, Hou, Li, Zhan, Lin, Lu, Yuan, Sun (bib0010) 2018; 818
Ahn, Metallo (bib0001) 2015; 3
Nikiforov, Chandriani, O'Connell, Petrenko, Kotenko, Beavis, Sedivy, Cole (bib0023) 2002; 22
Son, Lyssiotis, Ying, Wang, Hua, Ligorio, Perera, Ferrone, Mullarky, Shyh-Chang, Kang, Fleming, Bardeesy, Asara, Haigis, DePinho, Cantley, Kimmelman (bib0028) 2013; 496
van Geldermalsen, Wang, Nagarajah, Marshall, Thoeng, Gao, Ritchie, Feng, Bailey, Deng, Harvey, Beith, Selinger, O'Toole, Rasko, Holst (bib0031) 2016; 35
Yu, Lin, Du, Zhao, Feng, Yu, Zhang, Li, Qian, Luo, Yuan, Sun (bib0035) 2016; 7
Zhao, Sun, Lin, Bai, Yu, Yuan, Zhang (bib0036) 2013; 29
Cotter (bib0006) 2009; 9
Fan, Ye, Kamphorst, Shlomi, Thompson, Rabinowitz (bib0013) 2014; 510
Chen, Dai, Zou, Chen, Rajamanickam, Feng, Zhuge, Qiu, Ye, Zhang, Liang (bib0005) 2017; 174
Tabas, Ron (bib0029) 2011; 13
Kimball, Shantz, Horetsky, Jefferson (bib0019) 1999; 274
Esslinger, Cybulski, Rhoderick (bib0012) 2005; 13
Scott, Lamb, Smith, Wheatley (bib0026) 2000; 83
Diebold, Chandel (bib0009) 2016; 100
Duran, Oppliger, Robitaille, Heiserich, Skendaj, Gottlieb, Hall (bib0011) 2012; 47
Lu, Chen, Tao, Gao, Li, Cao, Lu, Zou (bib0022) 2017; 8
Breckenridge, Xue (bib0004) 2004; 16
DeBerardinis, Mancuso, Daikhin, Nissim, Yudkoff, Wehrli, Thompson (bib0007) 2007; 104
Yang, Moss, Mangala, Marini, Zhao, Wahlig, Armaiz-Pena, Jiang, Achreja, Win, Roopaimoole, Rodriguez-Aguayo, Mercado-Uribe, Lopez-Berestein, Liu, Tsukamoto, Sood, Ram, Nagrath (bib0033) 2014; 10
Bernstock, Ye (bib0002) 2017; 7
Wang, Hardie, Hoy, van Geldermalsen, Gao, Fazli, Sadowski, Balaban, Schreuder, Nagarajah, Wong, Metierre, Pinello, Otte, Lehman, Gleave, Nelson, Bailey, Ritchie, Rasko, Holst (bib0032) 2015; 236
Helfinger, Schroder (bib0015) 2018; 63
Labuschagne, van den Broek, Mackay, Vousden, Maddocks (bib0020) 2014; 7
Locasale (bib0021) 2013; 13
Bleicken, Wagner, Garcia-Saez (bib0003) 2013; 104
Kaufmann, Gores (bib0018) 2015; 22
Hara (10.1016/j.phymed.2018.12.011_bib0014) 1998; 273
Shanware (10.1016/j.phymed.2018.12.011_bib0027) 2011; 89
Labuschagne (10.1016/j.phymed.2018.12.011_bib0020) 2014; 7
Helfinger (10.1016/j.phymed.2018.12.011_bib0015) 2018; 63
Chen (10.1016/j.phymed.2018.12.011_bib0005) 2017; 174
Breckenridge (10.1016/j.phymed.2018.12.011_bib0004) 2004; 16
Esslinger (10.1016/j.phymed.2018.12.011_bib0012) 2005; 13
Wang (10.1016/j.phymed.2018.12.011_bib0032) 2015; 236
Yang (10.1016/j.phymed.2018.12.011_bib0033) 2014; 10
Diebold (10.1016/j.phymed.2018.12.011_bib0009) 2016; 100
Nikiforov (10.1016/j.phymed.2018.12.011_bib0023) 2002; 22
Kimball (10.1016/j.phymed.2018.12.011_bib0019) 1999; 274
Zhao (10.1016/j.phymed.2018.12.011_bib0036) 2013; 29
Desagher (10.1016/j.phymed.2018.12.011_bib0008) 2000; 10
Cotter (10.1016/j.phymed.2018.12.011_bib0006) 2009; 9
Pavlova (10.1016/j.phymed.2018.12.011_bib0024) 2016; 23
Bernstock (10.1016/j.phymed.2018.12.011_bib0002) 2017; 7
Du (10.1016/j.phymed.2018.12.011_bib0010) 2018; 818
Duran (10.1016/j.phymed.2018.12.011_bib0011) 2012; 47
Ahn (10.1016/j.phymed.2018.12.011_bib0001) 2015; 3
Lu (10.1016/j.phymed.2018.12.011_bib0022) 2017; 8
Fan (10.1016/j.phymed.2018.12.011_bib0013) 2014; 510
Phang (10.1016/j.phymed.2018.12.011_bib0025) 2012; 2
DeBerardinis (10.1016/j.phymed.2018.12.011_bib0007) 2007; 104
Kaufmann (10.1016/j.phymed.2018.12.011_bib0018) 2015; 22
Locasale (10.1016/j.phymed.2018.12.011_bib0021) 2013; 13
Jain (10.1016/j.phymed.2018.12.011_bib0017) 2012; 336
Son (10.1016/j.phymed.2018.12.011_bib0028) 2013; 496
Ulrich-Merzenich (10.1016/j.phymed.2018.12.011_bib0030) 2009; 16
Yu (10.1016/j.phymed.2018.12.011_bib0035) 2016; 7
Tabas (10.1016/j.phymed.2018.12.011_bib0029) 2011; 13
Hensley (10.1016/j.phymed.2018.12.011_bib0016) 2013; 123
van Geldermalsen (10.1016/j.phymed.2018.12.011_bib0031) 2016; 35
Scott (10.1016/j.phymed.2018.12.011_bib0026) 2000; 83
Yang (10.1016/j.phymed.2018.12.011_bib0034) 2017; 19
Bleicken (10.1016/j.phymed.2018.12.011_bib0003) 2013; 104
References_xml – volume: 7
  start-page: 7425
  year: 2017
  ident: bib0002
  article-title: Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
  publication-title: Sci. Rep.
  contributor:
    fullname: Ye
– volume: 9
  start-page: 501
  year: 2009
  end-page: 507
  ident: bib0006
  article-title: Apoptosis and cancer: The genesis of a research field
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Cotter
– volume: 2
  start-page: 60
  year: 2012
  ident: bib0025
  article-title: The proline regulatory axis and cancer
  publication-title: Front. Oncol.
  contributor:
    fullname: Christian
– volume: 89
  start-page: 229
  year: 2011
  end-page: 236
  ident: bib0027
  article-title: Glutamine: Pleiotropic roles in tumor growth and stress resistance
  publication-title: J. Mol. Med.
  contributor:
    fullname: Abraham
– volume: 19
  start-page: 163
  year: 2017
  end-page: 194
  ident: bib0034
  article-title: Glutaminolysis: A hallmark of cancer metabolism
  publication-title: Ann. Rev. Biomed. Eng.
  contributor:
    fullname: Nagrath
– volume: 104
  start-page: 19345
  year: 2007
  end-page: 19350
  ident: bib0007
  article-title: Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  contributor:
    fullname: Thompson
– volume: 10
  start-page: 369
  year: 2000
  end-page: 377
  ident: bib0008
  article-title: Mitochondria as the central control point of apoptosis
  publication-title: Trends Cell Biol.
  contributor:
    fullname: Martinou
– volume: 13
  start-page: 1111
  year: 2005
  end-page: 1118
  ident: bib0012
  article-title: Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Rhoderick
– volume: 16
  start-page: 2
  year: 2009
  end-page: 16
  ident: bib0030
  article-title: Synergy research: Vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling
  publication-title: Phytomed. Int. J. Phytother. Phytopharmacol.
  contributor:
    fullname: Kraft
– volume: 3
  start-page: 1
  year: 2015
  ident: bib0001
  article-title: Mitochondria as biosynthetic factories for cancer proliferation
  publication-title: Cancer Metab.
  contributor:
    fullname: Metallo
– volume: 510
  start-page: 298
  year: 2014
  end-page: 302
  ident: bib0013
  article-title: Quantitative flux analysis reveals folate-dependent NADPH production
  publication-title: Nature
  contributor:
    fullname: Rabinowitz
– volume: 7
  start-page: 32990
  year: 2016
  end-page: 33003
  ident: bib0035
  article-title: Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo
  publication-title: Oncotarget
  contributor:
    fullname: Sun
– volume: 496
  start-page: 101
  year: 2013
  end-page: 105
  ident: bib0028
  article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
  publication-title: Nature
  contributor:
    fullname: Kimmelman
– volume: 23
  start-page: 27
  year: 2016
  end-page: 47
  ident: bib0024
  article-title: The emerging hallmarks of cancer metabolism
  publication-title: Cell Metab.
  contributor:
    fullname: Thompson
– volume: 100
  start-page: 86
  year: 2016
  end-page: 93
  ident: bib0009
  article-title: Mitochondrial ROS regulation of proliferating cells
  publication-title: Free Radical Biol. Med.
  contributor:
    fullname: Chandel
– volume: 336
  start-page: 1040
  year: 2012
  end-page: 1044
  ident: bib0017
  article-title: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
  publication-title: Science
  contributor:
    fullname: Mootha
– volume: 13
  start-page: 572
  year: 2013
  end-page: 583
  ident: bib0021
  article-title: Serine, glycine and one-carbon units: Cancer metabolism in full circle
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Locasale
– volume: 22
  start-page: 5793
  year: 2002
  end-page: 5800
  ident: bib0023
  article-title: A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Cole
– volume: 818
  start-page: 124
  year: 2018
  end-page: 131
  ident: bib0010
  article-title: DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo
  publication-title: Eur. J. Pharmacol.
  contributor:
    fullname: Sun
– volume: 47
  start-page: 349
  year: 2012
  end-page: 358
  ident: bib0011
  article-title: Glutaminolysis activates Rag-mTORC1 signaling
  publication-title: Mol. Cell
  contributor:
    fullname: Hall
– volume: 63
  start-page: 88
  year: 2018
  end-page: 98
  ident: bib0015
  article-title: Redox control in cancer development and progression
  publication-title: Mol. Aspects Med.
  contributor:
    fullname: Schroder
– volume: 123
  start-page: 3678
  year: 2013
  end-page: 3684
  ident: bib0016
  article-title: Glutamine and cancer: Cell biology, physiology, and clinical opportunities
  publication-title: J. Clin. Invest.
  contributor:
    fullname: DeBerardinis
– volume: 29
  start-page: 1379
  year: 2013
  end-page: 1386
  ident: bib0036
  article-title: The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity
  publication-title: Oncol. Rep.
  contributor:
    fullname: Zhang
– volume: 174
  start-page: 1131
  year: 2017
  end-page: 1146
  ident: bib0005
  article-title: Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer
  publication-title: Br. J. Pharmacol.
  contributor:
    fullname: Liang
– volume: 273
  start-page: 14484
  year: 1998
  end-page: 14494
  ident: bib0014
  article-title: Amino acid sufficiency and mTOR regulate p70S6 kinase and eIF-4E BP1 through a common effector mechanism
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Avruch
– volume: 22
  start-page: 1007
  year: 2015
  end-page: 1017
  ident: bib0018
  article-title: Apoptosis in cancer: cause and cure
  publication-title: BioEssays
  contributor:
    fullname: Gores
– volume: 8
  start-page: 76458
  year: 2017
  end-page: 76467
  ident: bib0022
  article-title: Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo
  publication-title: Oncotarget
  contributor:
    fullname: Zou
– volume: 10
  start-page: 728
  year: 2014
  ident: bib0033
  article-title: Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
  publication-title: Mol. Syst. Biol.
  contributor:
    fullname: Nagrath
– volume: 13
  start-page: 184
  year: 2011
  end-page: 190
  ident: bib0029
  article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
  publication-title: Nat. Cell Biol.
  contributor:
    fullname: Ron
– volume: 274
  start-page: 11647
  year: 1999
  end-page: 11652
  ident: bib0019
  article-title: Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Jefferson
– volume: 236
  start-page: 278
  year: 2015
  end-page: 289
  ident: bib0032
  article-title: Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
  publication-title: J. Pathol.
  contributor:
    fullname: Holst
– volume: 83
  start-page: 800
  year: 2000
  end-page: 810
  ident: bib0026
  article-title: Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells
  publication-title: Br. J. Cancer
  contributor:
    fullname: Wheatley
– volume: 35
  start-page: 3201
  year: 2016
  end-page: 3208
  ident: bib0031
  article-title: ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
  publication-title: Oncogene
  contributor:
    fullname: Holst
– volume: 104
  start-page: 421
  year: 2013
  end-page: 431
  ident: bib0003
  article-title: Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis
  publication-title: Biophys. J.
  contributor:
    fullname: Garcia-Saez
– volume: 16
  start-page: 647
  year: 2004
  end-page: 652
  ident: bib0004
  article-title: Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases
  publication-title: Curr. Opin. Cell Biol.
  contributor:
    fullname: Xue
– volume: 7
  start-page: 1248
  year: 2014
  end-page: 1258
  ident: bib0020
  article-title: Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells
  publication-title: Cell Rep.
  contributor:
    fullname: Maddocks
– volume: 123
  start-page: 3678
  year: 2013
  ident: 10.1016/j.phymed.2018.12.011_bib0016
  article-title: Glutamine and cancer: Cell biology, physiology, and clinical opportunities
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI69600
  contributor:
    fullname: Hensley
– volume: 273
  start-page: 14484
  year: 1998
  ident: 10.1016/j.phymed.2018.12.011_bib0014
  article-title: Amino acid sufficiency and mTOR regulate p70S6 kinase and eIF-4E BP1 through a common effector mechanism
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.273.23.14484
  contributor:
    fullname: Hara
– volume: 7
  start-page: 1248
  year: 2014
  ident: 10.1016/j.phymed.2018.12.011_bib0020
  article-title: Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.04.045
  contributor:
    fullname: Labuschagne
– volume: 10
  start-page: 369
  year: 2000
  ident: 10.1016/j.phymed.2018.12.011_bib0008
  article-title: Mitochondria as the central control point of apoptosis
  publication-title: Trends Cell Biol.
  doi: 10.1016/S0962-8924(00)01803-1
  contributor:
    fullname: Desagher
– volume: 104
  start-page: 421
  year: 2013
  ident: 10.1016/j.phymed.2018.12.011_bib0003
  article-title: Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis
  publication-title: Biophys. J.
  doi: 10.1016/j.bpj.2012.12.010
  contributor:
    fullname: Bleicken
– volume: 818
  start-page: 124
  year: 2018
  ident: 10.1016/j.phymed.2018.12.011_bib0010
  article-title: DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2017.10.014
  contributor:
    fullname: Du
– volume: 13
  start-page: 1111
  year: 2005
  ident: 10.1016/j.phymed.2018.12.011_bib0012
  article-title: Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2004.11.028
  contributor:
    fullname: Esslinger
– volume: 23
  start-page: 27
  year: 2016
  ident: 10.1016/j.phymed.2018.12.011_bib0024
  article-title: The emerging hallmarks of cancer metabolism
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2015.12.006
  contributor:
    fullname: Pavlova
– volume: 29
  start-page: 1379
  year: 2013
  ident: 10.1016/j.phymed.2018.12.011_bib0036
  article-title: The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2013.2272
  contributor:
    fullname: Zhao
– volume: 3
  start-page: 1
  year: 2015
  ident: 10.1016/j.phymed.2018.12.011_bib0001
  article-title: Mitochondria as biosynthetic factories for cancer proliferation
  publication-title: Cancer Metab.
  doi: 10.1186/s40170-015-0128-2
  contributor:
    fullname: Ahn
– volume: 16
  start-page: 647
  year: 2004
  ident: 10.1016/j.phymed.2018.12.011_bib0004
  article-title: Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2004.09.009
  contributor:
    fullname: Breckenridge
– volume: 19
  start-page: 163
  year: 2017
  ident: 10.1016/j.phymed.2018.12.011_bib0034
  article-title: Glutaminolysis: A hallmark of cancer metabolism
  publication-title: Ann. Rev. Biomed. Eng.
  doi: 10.1146/annurev-bioeng-071516-044546
  contributor:
    fullname: Yang
– volume: 336
  start-page: 1040
  year: 2012
  ident: 10.1016/j.phymed.2018.12.011_bib0017
  article-title: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
  publication-title: Science
  doi: 10.1126/science.1218595
  contributor:
    fullname: Jain
– volume: 22
  start-page: 5793
  year: 2002
  ident: 10.1016/j.phymed.2018.12.011_bib0023
  article-title: A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.22.16.5793-5800.2002
  contributor:
    fullname: Nikiforov
– volume: 13
  start-page: 184
  year: 2011
  ident: 10.1016/j.phymed.2018.12.011_bib0029
  article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb0311-184
  contributor:
    fullname: Tabas
– volume: 174
  start-page: 1131
  year: 2017
  ident: 10.1016/j.phymed.2018.12.011_bib0005
  article-title: Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.13765
  contributor:
    fullname: Chen
– volume: 47
  start-page: 349
  year: 2012
  ident: 10.1016/j.phymed.2018.12.011_bib0011
  article-title: Glutaminolysis activates Rag-mTORC1 signaling
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2012.05.043
  contributor:
    fullname: Duran
– volume: 496
  start-page: 101
  year: 2013
  ident: 10.1016/j.phymed.2018.12.011_bib0028
  article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
  publication-title: Nature
  doi: 10.1038/nature12040
  contributor:
    fullname: Son
– volume: 7
  start-page: 32990
  year: 2016
  ident: 10.1016/j.phymed.2018.12.011_bib0035
  article-title: Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8843
  contributor:
    fullname: Yu
– volume: 13
  start-page: 572
  year: 2013
  ident: 10.1016/j.phymed.2018.12.011_bib0021
  article-title: Serine, glycine and one-carbon units: Cancer metabolism in full circle
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3557
  contributor:
    fullname: Locasale
– volume: 35
  start-page: 3201
  year: 2016
  ident: 10.1016/j.phymed.2018.12.011_bib0031
  article-title: ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2015.381
  contributor:
    fullname: van Geldermalsen
– volume: 510
  start-page: 298
  year: 2014
  ident: 10.1016/j.phymed.2018.12.011_bib0013
  article-title: Quantitative flux analysis reveals folate-dependent NADPH production
  publication-title: Nature
  doi: 10.1038/nature13236
  contributor:
    fullname: Fan
– volume: 7
  start-page: 7425
  year: 2017
  ident: 10.1016/j.phymed.2018.12.011_bib0002
  article-title: Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-07631-9
  contributor:
    fullname: Bernstock
– volume: 2
  start-page: 60
  year: 2012
  ident: 10.1016/j.phymed.2018.12.011_bib0025
  article-title: The proline regulatory axis and cancer
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2012.00060
  contributor:
    fullname: Phang
– volume: 274
  start-page: 11647
  year: 1999
  ident: 10.1016/j.phymed.2018.12.011_bib0019
  article-title: Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.17.11647
  contributor:
    fullname: Kimball
– volume: 16
  start-page: 2
  year: 2009
  ident: 10.1016/j.phymed.2018.12.011_bib0030
  article-title: Synergy research: Vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling
  publication-title: Phytomed. Int. J. Phytother. Phytopharmacol.
  contributor:
    fullname: Ulrich-Merzenich
– volume: 236
  start-page: 278
  year: 2015
  ident: 10.1016/j.phymed.2018.12.011_bib0032
  article-title: Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
  publication-title: J. Pathol.
  doi: 10.1002/path.4518
  contributor:
    fullname: Wang
– volume: 100
  start-page: 86
  year: 2016
  ident: 10.1016/j.phymed.2018.12.011_bib0009
  article-title: Mitochondrial ROS regulation of proliferating cells
  publication-title: Free Radical Biol. Med.
  doi: 10.1016/j.freeradbiomed.2016.04.198
  contributor:
    fullname: Diebold
– volume: 8
  start-page: 76458
  year: 2017
  ident: 10.1016/j.phymed.2018.12.011_bib0022
  article-title: Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.19479
  contributor:
    fullname: Lu
– volume: 10
  start-page: 728
  year: 2014
  ident: 10.1016/j.phymed.2018.12.011_bib0033
  article-title: Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
  publication-title: Mol. Syst. Biol.
  doi: 10.1002/msb.20134892
  contributor:
    fullname: Yang
– volume: 9
  start-page: 501
  year: 2009
  ident: 10.1016/j.phymed.2018.12.011_bib0006
  article-title: Apoptosis and cancer: The genesis of a research field
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2663
  contributor:
    fullname: Cotter
– volume: 89
  start-page: 229
  year: 2011
  ident: 10.1016/j.phymed.2018.12.011_bib0027
  article-title: Glutamine: Pleiotropic roles in tumor growth and stress resistance
  publication-title: J. Mol. Med.
  doi: 10.1007/s00109-011-0731-9
  contributor:
    fullname: Shanware
– volume: 22
  start-page: 1007
  year: 2015
  ident: 10.1016/j.phymed.2018.12.011_bib0018
  article-title: Apoptosis in cancer: cause and cure
  publication-title: BioEssays
  doi: 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4
  contributor:
    fullname: Kaufmann
– volume: 63
  start-page: 88
  year: 2018
  ident: 10.1016/j.phymed.2018.12.011_bib0015
  article-title: Redox control in cancer development and progression
  publication-title: Mol. Aspects Med.
  doi: 10.1016/j.mam.2018.02.003
  contributor:
    fullname: Helfinger
– volume: 83
  start-page: 800
  year: 2000
  ident: 10.1016/j.phymed.2018.12.011_bib0026
  article-title: Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells
  publication-title: Br. J. Cancer
  doi: 10.1054/bjoc.2000.1353
  contributor:
    fullname: Scott
– volume: 104
  start-page: 19345
  year: 2007
  ident: 10.1016/j.phymed.2018.12.011_bib0007
  article-title: Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
  contributor:
    fullname: DeBerardinis
SSID ssj0014970
Score 2.4254167
Snippet Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase...
BACKGROUNDTopotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 117
SubjectTerms Apoptosis
ASCT2
Gastric cancer
Oxidative stress
Topotecan
Title Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer
URI https://dx.doi.org/10.1016/j.phymed.2018.12.011
https://www.ncbi.nlm.nih.gov/pubmed/30668314
https://search.proquest.com/docview/2179423389
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7BIlVcqkJ5bEuRkRAnzCaON2sfV6uibVcgCovKzfLaCUoPSUSWqlz625nJA8QBIZFLlChWHM9kvm_smTHA4dB7tcCDS6djjngtuZaB5CrViBhOOyEpOfnsPJ5ey583w5sVmHS5MBRW2dr-xqbX1rq9M2hHc1Bm2eAKHRO0rCEpZYA0XK3CGsKRlD1YG_-YTc-fFhOkrveMo-c5Negy6OowL_wYhB2K8VL1vGAYvoZQrzHQGolOP8HHlkKycdPLDVhJ8k34cNYukm_C0UVTjvrhmM2fs6uqY3bELp4LVT98hl_zoqQqDTZn6JmjjCtmy6JcFlVWsb-ZZeOryVywOrkEiSkr_mW-rhPOmgwTbMVuLW384Zgj7bnbguvT7_PJlLdbLHCHyLXk3iWIktHQK6tFir6ST6PYS--CVJDrKFxiUxtElupyBaNYq1AKr52NVIrc0Ubb0MuLPNkF5tOUuMZoIaKhtNIthLZUOx59Hq-QdfaBd8NqyqaShulCzP6YRgyGxGBCYVAMfRh1Y29eaIRBY_9Gy4NOVAZ_FloBsXlS3FdGkPkR6JXrPuw0MnzqCypRrKJQfnn3e7_COl7pJq5nD3rLu_vkG1KW5WIfVk_-h_utYtJ5dvl79ghq4evH
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED51Rdr2gli3sQ7YPAnxhNXEcVL7sapAZaUVE0HizXLtBIWHJCIFwX-_c36AeKiQyGMSK87d5e67-O4zwGForVjhQbmREcV4zankHqcilRgxjDSMu-bkxTKaXfG_1-F1D6ZdL4wrq2x9f-PTa2_dnhm10hyVWTa6xMQEPavvjNJDGC4-wBYPxz7vw9bkbD5bPi8mcFnvGefup25A10FXl3nhy2DYcTVeov4v6PubItQmBFpHotMd2G4hJJk0s_wCvSQfwMdFu0g-gKOLho766ZjEL91V1TE5IhcvRNVPX-FfXJSOpUHnBDNz1HFFdFmU66LKKvKQaTK5nMaM1M0lCExJ8ZjZmiecNB0mOIrcaLfxhyHGWc_dN7g6PYmnM9pusUANRq41tSbBKBmEVmjJUsyVbBpEllvjpcyljswkOtVeoB0vlzeOpPA5s9LoQKSIHXXwHfp5kSc_gNg0dVhjvGJByDU3Kya1447HnMcKRJ1DoJ1YVdkwaaiuxOxWNWpQTg3KZwrVMIRxJ3v1yiIUOvs3Rv7pVKXwY3ErIDpPivtKMed-GGblcgi7jQ6f54JGFInA5z_f_dzf8GkWL87V-dlyvgef8Ypsanz2ob--u08OEL6sV79a8_wPudjsFg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Topotecan+induces+apoptosis+via+ASCT2+mediated+oxidative+stress+in+gastric+cancer&rft.jtitle=Phytomedicine+%28Stuttgart%29&rft.au=Wang%2C+Lai&rft.au=Liu%2C+Yang&rft.au=Zhao%2C+Ting-Li&rft.au=Li%2C+Zheng-Zheng&rft.date=2019-04-01&rft.pub=Elsevier+GmbH&rft.issn=0944-7113&rft.eissn=1618-095X&rft.volume=57&rft.spage=117&rft.epage=128&rft_id=info:doi/10.1016%2Fj.phymed.2018.12.011&rft.externalDocID=S0944711318306068
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-7113&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-7113&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-7113&client=summon